Thomas DiRaimondo
Director Técnico/Científico/I+D en JANUX THERAPEUTICS, INC. .
Fortuna: 5 M $ al 31/05/2024
Cargos activos de Thomas DiRaimondo
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| JANUX THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/05/2018 | - |
Historial de carrera de Thomas DiRaimondo
Antiguos cargos conocidos de Thomas DiRaimondo.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Sitari Pharma, Inc.
 Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Fundador | 01/01/2013 | 01/08/2019 |
Formación de Thomas DiRaimondo.
| Stanford University | Doctorate Degree |
| University of Michigan | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Founder | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| JANUX THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas DiRaimondo
- Experiencia
